All News

    A VXM01 Vaccine Combination Generates Safe Responses in Glioblastoma

    March 26th 2025, 9:00pm

    Article

    Treatment with VXM01, an investigational vaccine, plus Bavencio demonstrated both safety and tolerability in patients with recurrent glioblastoma.

    A Patient Advocate Highlights Kidney Cancer Awareness and Specialized Care

    March 26th 2025, 8:00pm

    Video

    Sid Sadler discusses kidney cancer awareness, patient advocacy and the need for specialized care to improve access to treatments and clinical trials.

    Communication is Key When Transitioning Multiple Myeloma Care

    March 26th 2025, 7:00pm

    Article

    A panel of experts discussed the transition of care between community and academic centers at the CURE Educated Patient Multiple Myeloma Summit.

    Surviving Scans While Surviving Breast Cancer

    March 26th 2025, 5:00pm

    Article

    Survivors facing new medical concerns may fear the unknown, but perseverance is possible as they navigate unexpected challenges in their new normal.

    Progress Reported in Phase 1 Trial of CLD-101 for Recurrent Glioma

    March 26th 2025, 4:00pm

    Article

    A progress report for a phase 1 trial of CLD-101 in recurrent glioma shows safety and feasibility at multiple intracerebral doses.

    FDA Approves Cabometyx for Some Neuroendocrine Tumors

    March 26th 2025, 1:44pm

    Article

    The FDA has approved Cabometyx for some patients 12 years old and older with pancreatic neuroendocrine tumors and extra-pancreatic neuroendocrine tumors.

    Navigating a Colorectal Cancer Diagnosis at a Young Age

    March 26th 2025, 1:00pm

    Article

    Melissa Ursini discussed her experience with a colorectal cancer diagnosis at age 37, highlighting her insights during Colorectal Cancer Awareness Month.

    EU Approves Rytelo for Transfusion-Dependent Anemia in Low-Risk MDS

    March 25th 2025, 9:00pm

    Article

    The European Commission has approved Rytelo treatment in transfusion-dependent anemia due to very low–, low– or intermediate-risk myelodysplastic syndrome.

    Top 3 Takeaways From ASCO GU 2025

    March 25th 2025, 8:16pm

    Video

    Dr. Emre Yekedüz discusses his top 3 key takeaways from attending the 2025 ASCO Genitourinary (GU) Cancers Symposium.

    New Cancer Vaccine, EVM14, Cleared for Investigational Drug Application

    March 25th 2025, 7:05pm

    Article

    EVM14 received FDA clearance for clinical trials, marking Everest Medicines’ first in-house developed therapeutic to reach this stage.